dc.contributor.author | Camlica, H | |
dc.contributor.author | Ustuner, Z | |
dc.contributor.author | Karagol, H | |
dc.contributor.author | Aksu, G | |
dc.contributor.author | Aykan, NF | |
dc.contributor.author | Sakar, B | |
dc.date.accessioned | 2021-03-04T14:29:13Z | |
dc.date.available | 2021-03-04T14:29:13Z | |
dc.date.issued | 2004 | |
dc.identifier.citation | Sakar B., Ustuner Z., Karagol H., Aksu G., Camlica H., Aykan N., "Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, cilt.27, sa.5, ss.489-493, 2004 | |
dc.identifier.issn | 0277-3732 | |
dc.identifier.other | av_81d4cc8e-028d-42f9-9ee4-bb5ae769bb7c | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/88442 | |
dc.identifier.uri | https://doi.org/10.1097/01.coc.0000136019.94333.09 | |
dc.description.abstract | Background: Primary hepatocellular carcinoma (HCC) is common in Turkey and its prognosis is poor. In the current study the authors analyzed the prognostic factors and survival in Turkish patients with inoperable HCC with cirrhosis. | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.title | Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis | |
dc.type | Makale | |
dc.relation.journal | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | |
dc.contributor.department | , , | |
dc.identifier.volume | 27 | |
dc.identifier.issue | 5 | |
dc.identifier.startpage | 489 | |
dc.identifier.endpage | 493 | |
dc.contributor.firstauthorID | 172676 | |